Serbia to India: Brufen Import Trade Route

The Serbia to India Brufen corridor is one of India's established pharmaceutical import routes from Serbia, with 1 shipments documented worth a combined $2 USD. The route is dominated by M/S. GALENIKA AD , which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Serbia's brufen export sector.

Across 1 active Serbia suppliers, the average shipment value stands at $2 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with brufen's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 20.3%, placing it at rank #3 among India's top brufen import origins globally.

On the Indian buyer side, key Indian importers include SYNGENE INTERNATIONAL LIMITED . SYNGENE INTERNATIONAL LIMITED is the single largest Indian importer with 1 shipments valued at $2 USD.

India's brufen imports from Serbia are driven primarily by a handful of large-scale Serbia manufacturers. M/S. GALENIKA AD with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Serbia supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — M/S. GALENIKA AD — together account for 100% of total trade value on this route. The average shipment value of $2 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, SYNGENE INTERNATIONAL LIMITED is the largest importer with 1 shipments worth $2 USD — representing 100% of all brufen imports from Serbia on this route.